Quality assurance guidelines for superior vena cava stenting in malignant disease.
Superior vena cava stenting for the treatment of malignant superior vena cava obstruction is now well established. It offers simple, rapid, and safe palliation of a distressing and potentially fatal complication of mediastinal malignant disease and compares very favorably with standard therapies such as chemotherapy and radiotherapy. The following are quality assurance guidelines for superior vena cava stenting.
Uberoi
Raman
R
Department of Radiology, The John Radcliffe Hospital, Headington, Oxford, UK. raman.uberoi@orh.nhs.uk
D006801:Humans; D010166:Palliative Care; D011785:Quality Assurance, Health Care; D015641:Radiography, Interventional; D015607:Stents; D013479:Superior Vena Cava Syndrome / Q000628:therapy*